|
Clobetasol is an effective medication used for the treatment of
allergic reactions, eczema or psoriasis. The brand name under which
it is available, Olux came into existence on 28th October 2005 in
the Galderma laboratories. It was Galderma who declared that the
drug had get its approval from the Food and Drug Administration of
United States (US).With this approval from FDA Clobetasol was
granted the sale in the markets and its manufacturing was started.
Clobetasol was made available in the form of spray 0.05%.This spray
is capable of treating moderate as well as severe plague
psoriasis.Infact this spray has the monopoly in the market for
having super high potential for corticosteroid formulation. This
fact itself proves the clinical strength of clobetasol which results
in highly advanced, convenient and also non-aerosol formulation.
Clobetasol spray is a very effective medication, this was proved by
the clinical trails that were held to prove its efficiency and
acknowledge its power.
Of 209 patients who under went the tests 82% to 85% were satisfied
with the treatment and also showed the best results. The duration
for this satisfaction required around four weeks. Of these 45%
patients did clear in as early as two weeks only. With its powerful
effects for shielding the problems faced due to various skin
reactions and allergies.
The future of this medication seems to be bright with high sales in
the market. Much earlier than this on 31st may 2000 Palo Alto CA
Connetics Corporation had declared market clearance to Olux (Clobetasol
propionate), this was also a decision of FDA.
|
